PDR Network Introduces New Adverse Drug Event Reporting System
PDR Network introduces RxEvent, a new online network to collect and distribute adverse drug events now available to all US prescribers via integration into electronic health record platforms and other online services, including directly at www.RxEvent.org.
Roughly half a million adverse drug events are reported annually to the FDA, with over 90 percent of these reports coming from pharmaceutical manufacturers who receive them from physicians and other providers via telephone. This legacy call center-based system is expensive for manufacturers and inconvenient and time-consuming by physicians; it is not surprising that studies show as few as one in ten ADEs are actually reported by healthcare professionals due to this cumbersome process. RxEvent addresses this issue by offering physicians a new way to report ADEs quickly and easily from within their workflow to improve the quality, timeliness, and overall reporting of adverse events.
RxEvent benefits include:
· Decreasing costs associated with current call centers and backend manual processing and reporting;
· Improving reporting quality and rates by physicians and pharmacists by placing the system within their workflow;
· Increasing data mining value through report customization and electronic data gathering; and
· Allowing for monitoring of off-label use and new side effects developing with approved use.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
